Provided by Tiger Trade Technology Pte. Ltd.

Abbott Laboratories

116.13
-0.5400-0.46%
Post-market: 115.70-0.4300-0.37%19:59 EDT
Volume:7.50M
Turnover:869.78M
Market Cap:201.94B
PE:37.58
High:116.61
Open:115.83
Low:115.04
Close:116.67
52wk High:137.49
52wk Low:81.97
Shares:1.74B
Float Shares:1.70B
Volume Ratio:0.97
T/O Rate:0.44%
Dividend:2.48
Dividend Rate:2.14%
EPS(TTM):3.09
EPS(LYR):3.73
ROE:10.58%
ROA:5.33%
PB:3.95
PE(LYR):31.13

Loading ...

Movement Alert|Abbott Laboratories Falls 3.08% in Regular Trading, Multiple Banks Cut Target Prices Triggering Pullback Pressure

Market Focus
·
Jul 30

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 30

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 29

Abbott Laboratories Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 29

Abbott Labs is Maintained at Buy by UBS

Dow Jones
·
Jul 29

Movement Alert|Abbott Laboratories Rises 3.07% in Regular Trading, FDA Approves Its Exclusive Colorectal Cancer Blood Screening Test

Market Focus
·
Jul 28

Abbott price target lowered to $125 from $135 at UBS

TIPRANKS
·
Jul 28

Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating

MT Newswires Live
·
Jul 28

Abitare In Publishes 2025 Sustainability Report, Underscoring Urban Regeneration Strategy

TIPRANKS
·
Jul 28

Leah Bennett: Where to Invest After the AI-Chip Stock Surge

Dow Jones
·
Jul 27

Freenome, Abbott Laboratories' Colorectal Cancer Screening Test Approved by FDA; Freenome Earns $100 Million Milestone Payment

MT Newswires Live
·
Jul 27

US Companies Face Rise in Cyber Attacks

Reuters
·
Jul 27

FDA Approves Freenome’S Simplescreen™ Crc Blood-Based Screening Test Abbott to Commercialize in the U.S.

Reuters
·
Jul 27

Freenome, Abbott announce FDA approval of SimpleScreen CRC

TIPRANKS
·
Jul 27

Freenome- Freenome to Receive $100 Mln Milestone Payment from Abbott for FDA Approval

THOMSON REUTERS
·
Jul 27

Dexcom Inc. Stock Underperforms Friday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 25

Abbott Laboratories Wins Dismissal of Shareholder Lawsuit Stemming from 2022 Infant Formula Recall, Court Ruling Shows

THOMSON REUTERS
·
Jul 25

Abbott Wins Dismissal of Shareholder Lawsuit over 2022 Infant Formula Recall

Reuters
·
Jul 25

Abitare In Publishes Shareholders’ Meeting Voting Summary

TIPRANKS
·
Jul 25

Movement Alert|Abbott Laboratories Rises 3.03% in Regular Trading, Multiple Institutions Raise Target Prices Following Strong Q2 Earnings

Market Focus
·
Jul 24